Selected article for: "local lung and lung disease"

Author: Björkström, Niklas K; Ponzetta, Andrea
Title: Natural killer cells and unconventional T cells in COVID-19
  • Cord-id: jmfoewkz
  • Document date: 2021_6_19
  • ID: jmfoewkz
    Snippet: NK cells and diverse populations of unconventional T cells, such as MAIT cells, γδ T cells, invariant NKT cells, and DNT(ɑβ) cells are important early effector lymphocytes. While some of these cells, such as NK cell and MAIT cells, have well-established roles in antiviral defense, the function of other populations remains more elusive. Here, we summarize and discuss current knowledge on NK cell and unconventional T cell responses to SARS-CoV-2 infection. Also covered is the role of these cel
    Document: NK cells and diverse populations of unconventional T cells, such as MAIT cells, γδ T cells, invariant NKT cells, and DNT(ɑβ) cells are important early effector lymphocytes. While some of these cells, such as NK cell and MAIT cells, have well-established roles in antiviral defense, the function of other populations remains more elusive. Here, we summarize and discuss current knowledge on NK cell and unconventional T cell responses to SARS-CoV-2 infection. Also covered is the role of these cells in the pathogenesis of severe COVID-19. Understanding the early, both systemic and local (lung), effector lymphocyte response in this novel disease will likely aid ongoing efforts to combat the pandemic.

    Search related documents:
    Co phrase search for related documents
    • aberrant immune response and acute sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • aberrant immune response and acute sars infection: 1, 2, 3
    • aberrant immune response and adaptive immune response: 1
    • activating receptor and acute sars: 1, 2, 3, 4, 5
    • activating receptor and acute sars infection: 1, 2, 3
    • activation marker and acute influenza: 1
    • activation marker and acute sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • activation marker and acute sars infection: 1, 2, 3, 4
    • activation marker and acute viral infection: 1
    • activation marker and adaptive immune response: 1
    • acute influenza and adaptive immune response: 1, 2, 3, 4, 5, 6
    • acute sars and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13